However, treatment with CEP (15 mg/kg) or PFD significantly downregulated the TGF-β1 and α-SMA protein levels in the lung tissues when compared with those in the BLM group (p < 0.01). Here, TGFB1 is linked to polyostotic fibrous dysplasia.